Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-10 Purchase | 2025-02-12 5:21 pm | Sionna Therapeutics Inc. | SION | TPG GP A LLC COULTER JAMES G WINKELRIED JON 10% Owner | 1,125,000 | $18 | $20,250,000 | 6,684,962 (Indirect) | View |
| 2025-02-10 Purchase | 2025-02-10 5:04 pm | Sionna Therapeutics Inc. | SION | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,125,000 | $18 | $20,250,000 | 2,324,498 (Indirect) | View |
| 2025-02-10 Purchase | 2025-02-10 4:28 pm | Sionna Therapeutics Inc. | SION | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 550,000 | $18 | $9,900,000 | 3,704,959 (Indirect) | View |
| 2025-02-10 Purchase | 2025-02-10 4:05 pm | Sionna Therapeutics Inc. | SION | Thompson Peter A. Director | 550,000 | $18 | $9,900,000 | 3,704,959 (Indirect) | View |
| 2025-02-10 Purchase | 2025-02-10 4:05 pm | Sionna Therapeutics Inc. | SION | Booth Bruce Director | 60,000 | $18 | $1,080,000 | 807,727 (Indirect) | View |
| 2025-02-10 Purchase | 2025-02-10 4:05 pm | Sionna Therapeutics Inc. | SION | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner | 60,000 | $18 | $1,080,000 | 3,694,020 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-04-01 4:05 pm | N/A 2034-07-14 | Sionna Therapeutics Inc. | SION | Fitzpatrick Jennifer Chief Legal Officer | 0 | $0 | 267,835 (Direct) | View |
| 2025-02-10 Conversion | 2025-02-12 5:21 pm | N/A N/A | Sionna Therapeutics Inc. | SION | TPG GP A LLC COULTER JAMES G WINKELRIED JON 10% Owner | 11,999,210 | $0 | 6,684,962 (Indirect) | View |
| 2025-02-10 Conversion | 2025-02-10 5:04 pm | N/A N/A | Sionna Therapeutics Inc. | SION | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 19,569,422 | $0 | 2,324,498 (Indirect) | View |
| 2025-02-10 Conversion | 2025-02-10 4:28 pm | N/A N/A | Sionna Therapeutics Inc. | SION | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 7,764,670 | $0 | 3,704,959 (Indirect) | View |
| 2025-02-06 Option Award | 2025-02-10 4:05 pm | N/A 2035-02-05 | Sionna Therapeutics Inc. | SION | Ruddy Marcella K. Director | 39,919 | $0 | 39,919 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-10 4:05 pm | N/A 2035-02-05 | Sionna Therapeutics Inc. | SION | Viney Joanne L. Director | 39,919 | $0 | 39,919 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-10 4:05 pm | N/A 2035-02-05 | Sionna Therapeutics Inc. | SION | Cloonan Michael President & CEO | 450,252 | $0 | 450,252 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-10 4:05 pm | N/A 2035-02-05 | Sionna Therapeutics Inc. | SION | Ridloff Elena CFO & Head of Corp. Dev. | 157,820 | $0 | 157,820 (Direct) | View |
| 2025-02-10 Conversion | 2025-02-10 4:05 pm | N/A N/A | Sionna Therapeutics Inc. | SION | Thompson Peter A. Director | 7,764,670 | $0 | 3,704,959 (Indirect) | View |
| 2025-02-10 Conversion | 2025-02-10 4:05 pm | N/A N/A | Sionna Therapeutics Inc. | SION | Booth Bruce Director | 8,943,687 | $0 | 807,727 (Indirect) | View |
| 2025-02-10 Conversion | 2025-02-10 4:05 pm | N/A N/A | Sionna Therapeutics Inc. | SION | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner | 8,943,687 | $0 | 3,694,020 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-10 4:05 pm | N/A 2035-02-05 | Sionna Therapeutics Inc. | SION | McKee Charlotte Chief Medical Officer | 148,536 | $0 | 148,536 (Direct) | View |
Ownership | 2025-02-06 9:36 pm | N/A N/A | Sionna Therapeutics Inc. | SION | TPG GP A LLC COULTER JAMES G WINKELRIED JON 10% Owner | 0 | $0 | 5,559,962 (Indirect) | View |
Ownership | 2025-02-06 9:22 pm | N/A 2034-11-13 | Sionna Therapeutics Inc. | SION | Stelzer Laurie Director | 0 | $0 | 44,480 (Direct) | View |
Ownership | 2025-02-06 9:18 pm | N/A N/A | Sionna Therapeutics Inc. | SION | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 0 | $0 | 3,154,959 (Indirect) | View |
Ownership | 2025-02-06 9:18 pm | N/A N/A | Sionna Therapeutics Inc. | SION | McKee Charlotte Chief Medical Officer | 0 | $0 | 277,300 (Direct) | View |
Ownership | 2025-02-06 9:12 pm | N/A N/A | Sionna Therapeutics Inc. | SION | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner | 0 | $0 | 3,634,020 (Direct) | View |
Ownership | 2025-02-06 9:09 pm | N/A N/A | Sionna Therapeutics Inc. | SION | Cloonan Michael President & CEO | 0 | $0 | 1,536,786 (Direct) | View |
Ownership | 2025-02-06 9:07 pm | N/A N/A | Sionna Therapeutics Inc. | SION | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 9,320,322 (Indirect) | View |
Ownership | 2025-02-06 9:06 pm | N/A N/A | Sionna Therapeutics Inc. | SION | Thompson Peter A. Director | 0 | $0 | 3,154,959 (Indirect) | View |
Ownership | 2025-02-06 9:02 pm | N/A 2032-05-25 | Sionna Therapeutics Inc. | SION | Clancy Paul J Director | 0 | $0 | 185,485 (Direct) | View |
Ownership | 2025-02-06 9:00 pm | N/A N/A | Sionna Therapeutics Inc. | SION | Ridloff Elena CFO & Head of Corp. Dev. | 0 | $0 | 411,397 (Direct) | View |
Ownership | 2025-02-06 8:58 pm | N/A N/A | Sionna Therapeutics Inc. | SION | Booth Bruce Director | 0 | $0 | 3,634,020 (Indirect) | View |